Literature DB >> 1403018

Local botulinum toxin in the treatment of spastic drop foot.

R Dengler1, U Neyer, K Wohlfarth, U Bettig, H H Janzik.   

Abstract

Ten patients with spastic drop foot were treated by local injections of botulinum toxin A (botulinum toxin A haemagglutinin complex). The purpose was to improve stance and gait and/or to facilitate physiotherapy and patient care. Various calf muscles were injected using EMG guidance. The average dose used was 23 ng. Prior to and 4 weeks after treatment, positions of the upper and lower ankle joint at rest and the corresponding end positions of passive and active movement were determined. In addition, changes of spasticity and pain, the transmission phenomenon and stance and gait were evaluated. Most patients showed improvement of some aspects of the spastic drop foot. Positions of the upper and lower ankle joint were improved in most of the patients, as were the other parameters examined. Except for weakness of the injected muscles no side-effects were observed. The results appear promising and may be optimized in further trials by using higher doses of the toxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403018     DOI: 10.1007/bf00812153

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.

Authors:  B ASHWORTH
Journal:  Practitioner       Date:  1964-04

Review 2.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

3.  Writer's cramp: treatment with botulinum toxin injections.

Authors:  J Rivest; A J Lees; C D Marsden
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

4.  Botulinum toxin A in orthopaedic surgery.

Authors:  T Gasser; K Fritsch; G Arnold; W Oertel
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

5.  Ear click in palatal tremor: its origin and treatment with botulinum toxin.

Authors:  G Deuschl; E Löhle; F Heinen; C Lücking
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

6.  Botulinum toxin in treating spasticity.

Authors:  T K Das; D M Park
Journal:  Br J Clin Pract       Date:  1989-11

7.  Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Authors:  M F Brin; S Fahn; C Moskowitz; A Friedman; H M Shale; P E Greene; A Blitzer; T List; D Lange; R E Lovelace
Journal:  Adv Neurol       Date:  1988

8.  Treatment of spasticity with botulinum toxin: a double-blind study.

Authors:  B J Snow; J K Tsui; M H Bhatt; M Varelas; S A Hashimoto; D B Calne
Journal:  Ann Neurol       Date:  1990-10       Impact factor: 10.422

Review 9.  [Botulinum toxin in therapy of craniocervical dystonia].

Authors:  D Dressler; R Benecke; B Conrad
Journal:  Nervenarzt       Date:  1989-07       Impact factor: 1.214

10.  Treatment of focal dystonias of the hand with botulinum toxin injections.

Authors:  L G Cohen; M Hallett; B D Geller; F Hochberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

View more
  14 in total

Review 1.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

2.  Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.

Authors:  D Richardson; G Sheean; D Werring; M Desai; S Edwards; R Greenwood; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 3.  Spasticity after stroke. Epidemiology and optimal treatment.

Authors:  C F O'Brien; L C Seeberger; D B Smith
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

4.  Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.

Authors:  S Hesse; D Lücke; M Malezic; C Bertelt; H Friedrich; M Gregoric; K H Mauritz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 5.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 6.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

8.  Treatment of chronic limb spasticity with botulinum toxin A.

Authors:  J W Dunne; N Heye; S L Dunne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

9.  [Botulinum toxin treatment : therapy success in cases of depression and ongoing pension applications].

Authors:  A Bachhuber; G Reichel; M Doberenz; A Stenner; W Hermann
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 10.  Poststroke motor dysfunction and spasticity: novel pharmacological and physical treatment strategies.

Authors:  Stefan Hesse; Cordula Werner
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.